Acupuncture Therapy in Patients With Subacromial Impingement Syndrome

Launched by FATIH SULTAN MEHMET TRAINING AND RESEARCH HOSPITAL · Mar 30, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at how acupuncture therapy may help patients with Subacromial Impingement Syndrome (SIS), a common cause of shoulder pain. The study aims to see if acupuncture can reduce pain, improve movement, enhance daily functioning, and boost overall quality of life for people diagnosed with this condition. While some previous studies have looked at acupuncture for shoulder pain, the results have been mixed, and researchers believe more thorough studies are needed.

To participate in this trial, individuals must be between 20 and 65 years old and have been diagnosed with SIS, experiencing moderate to severe shoulder pain for at least six weeks. However, those with other shoulder problems, recent treatments like physiotherapy or injections, or certain medical conditions will not be eligible. Participants can expect to receive acupuncture treatment and will be monitored for any changes in their symptoms and overall well-being throughout the study. This trial is not yet recruiting, but it represents an important step in exploring new treatments for shoulder pain.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Clinical diagnosis of Subacromial impingement syndrome
• • Age range from 20-65 years
• • Pain VAS ≥ 4
• • Shoulder impingement symptoms lasting at least 6 weeks
• Exclusion Criteria:
• • Presence of other shoulder pathologies
• • Previous applications of physiotherapy and injection of hyaluronic acid and/or corticosteroid during the preceding 3 months;
• • Presence of cervical pain or other conditions such as fibromyalgia confusing the clinical picture
• • Presence of malignancy, blood disorder, neurologic, motor, and/or sensory deficit in the upper extremity;
• • Pregnancy,
• • Local anesthetic allergy
• • Previous acupuncture treatment
• • History of deformities, fractures, or surgery of the shoulder